Level Four Advisory Services, LLC Adamis Pharmaceuticals Corp Transaction History

Level Four Advisory Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$0.66 - $1.23 $21,120 - $39,360	-32,000 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$0.52 - $1.45 $11,180 - $31,175	-21,500 Reduced 40.19%	32,000 $25,000
Q2 2020 Aug 17, 2020	BUY	$0.33 - $0.66 $17,655 - $35,310	53,500 New	53,500 $29,000
Q2 2020 Jul 27, 2020	SELL	$0.33 - $0.66 $17,655 - $35,310	-53,500 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$0.7 - $1.46 $7,000 - $14,600	-10,000 Reduced 15.75%	53,500 $38,000
Q2 2019 Aug 14, 2019	SELL	$1.26 - $2.23 $252 - $446	-200 Reduced 0.31%	63,500 $83,000
Q1 2019 May 15, 2019	SELL	$2.02 - $3.22 $5,050 - $8,050	-2,500 Reduced 3.78%	63,700 $134,000
Q3 2018 Nov 14, 2018	BUY	$2.25 - $4.8 $6,075 - $12,960	2,700 Added 4.25%	66,200 $232,000
Q2 2018 Aug 14, 2018	BUY	$3.2 - $4.7 $203,200 - $298,450	63,500 New	63,500 $203,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Level Four Advisory Services, LLC with notifications on news.